Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ: SAVA )

2.420 +0.040 (+1.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 Next >
SAVA ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cassava Sciences, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
CASSAVA SHAREHOLDER NOTICE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
CLASS ACTION UPDATE for REKR, BZ and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, PHG and SAVA
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News
Toward the end of trading Friday, the Dow traded up 0.63% to 35,436.38 while the NASDAQ rose 1.23% to 15,130.14. The S&P also rose, gaining 0.88% to 4,509.16. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Major Benchmarks Gain Amid Economic Stimulus Commentary
Investors are unpacking comments by Federal Reserve Chairman Jerome Powell. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Most Active Equity Options For Midday - Friday, Aug. 27
Top Tickers: AAPL, TSLA, AMD, NVDA, PLTR, AMC, BABA, PTON, BBIG, F, SPRT, MSFT, AMZN, FB, PFE, MRNA, BAC, NFLX, SAVA, MARA. 
Via Talk Markets
Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher
Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, gaining 0.79% to 4,505.38. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
35 Stocks Moving In Friday's Mid-Day Session
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential... 
Via Benzinga
Why the Cassava Sciences Bears Are Wrong
The stock's been a wild ride for investors all year, and it's dropped about 40% in two days. What's going on, and why am I bullish? 
Via The Motley Fool
Why Cassava Sciences Is Plunging Again Today
More red flags are emerging for this troubled Alzheimer's biotech company. 
Via The Motley Fool
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again. 
Via Investor's Business Daily
Why Cassava Sciences Stock Investors Are Pulling Back
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of... 
Via Benzinga
Which Biotech Stock Will Shock the Market in 2022?
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022? 
Via The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Big Lots Reports Downbeat Profit
Following the market opening Friday, the Dow traded up 0.30% to 35,320.11 while the NASDAQ rose 0.27% to 14,986.36. The S&P also rose, gaining 0.33% to 4,484.57. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
63 Biggest Movers From Yesterday
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
Via Benzinga
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences on Behalf of Cassava Sciences Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CASSAVA SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Traders Shouldn’t Bargain Hunt in Cassava Stock
Wall Street is notorious for its overreactions, but when it comes to SAVA stock's cratering, investors consider other historical precedents. 
Via InvestorPlace
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – SAVA
From The Rosen Law Firm, P.A.
Via Business Wire
As Allegations Swirl, Can Investors Still Count on Cassava Sciences Stock?
This once-promising biotech is now struggling to stay afloat. 
Via The Motley Fool
Exposures Product Safety
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment. 
Via The Motley Fool
GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends
GameStop Corp. (NYSE:GME) continued to be the most-discussed ... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
54 Biggest Movers From Yesterday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently... 
Via Benzinga
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
< Previous 1 2
...
30 31 32 33 34 35 36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.